Forskning ved Københavns Universitet - Københavns Universitet

Forside

A phase I study of the safety and pharmacokinetics of the histone deacetylase inhibitor belinostat administered in combination with carboplatin and/or paclitaxel in patients with solid tumours

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

  • Lassen, Ulrik Niels
  • L R Molife
  • Janice Marie Sorensen
  • S-A Engelholm
  • L Vidal
  • R Sinha
  • R T Penson
  • Jensen, Per
  • E Crowley
  • J Tjornelund
  • P Knoblauch
  • J S de Bono
  • P Buhl-Jensen
This phase I study assessed the maximum tolerated dose, dose-limiting toxicity (DLT) and pharmacokinetics of belinostat with carboplatin and paclitaxel and the anti-tumour activity of the combination in solid tumours.
OriginalsprogEngelsk
TidsskriftB J C
Vol/bind103
Udgave nummer1
Sider (fra-til)12-7
Antal sider6
ISSN0007-0920
DOI
StatusUdgivet - 29 jun. 2010

ID: 34079775